Crinetics.com

Crinetics Unveils Parathyroid Hormone Receptor Antagonist …

WEBCrinetics Pharmaceuticals to Unveil its Parathyroid Hormone Receptor Antagonist Program at the American Society for Bone and Mineral Research Annual Meeting. SAN DIEGO, …

Actived: 7 days ago

URL: https://crinetics.com/crinetics-unveils-parathyroid-hormone-receptor-antagonist-program-at-asbmr/

Crinetics Pharmaceuticals To Present Advancements From …

WEBDiseases associated with excess ACTH can have significant impact on physical and mental health. Atumelnant has exhibited strong binding affinity for MC2R in …

Category:  Health Go Health

About Crinetics Pharmaceuticals (CRNX) San Diego Pharma

WEBAbout Us. Our passion for this work runs deep. Crinetics was founded by a team of scientists with a track record of drug discovery and development. We are dedicated to …

Category:  Health Go Health

What Are Clinical Trials And Why Are They Important

WEBThe ultimate goal in clinical trials is to improve health outcomes. For people living with a rare disease like acromegaly, clinical trials can provide an opportunity to try new …

Category:  Health Go Health

Crinetics Pharmaceuticals

WEBCrinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) SAN DIEGO , April 11, 2024 (GLOBE NEWSWIRE) -- …

Category:  Health Go Health

Crinetics Pharmaceuticals Awarded National Institutes of Health …

WEBSAN DIEGO — February 7, 2009 — San Diego-based Crinetics Pharmaceuticals announced today that it has been awarded a Phase I Small Business Innovation …

Category:  Health Go Health

Carcinoid Syndrome, Symptoms, Diagnosis, Treatment

WEBFlushing. This is the clinical hallmark of carcinoid syndrome and occurs in 85% of NETs patients 5 who experience symptoms of carcinoid syndrome. Flushing is a sudden, …

Category:  Health Go Health

40th Annual J.P. Morgan Health Care Conference

WEBJan 12, 2022 at 4:30 PM EST. Scott Struthers, Ph.D., founder & CEO of Crinetics, will provide a company update at the 40th annual J.P. Morgan Healthcare Conference on …

Category:  Health Go Health

CRN04894, Demonstrates Pharmacologic Proof-of-Concept

WEBCrinetics will hold a conference call and live audio webcast today, August 10, 2021 at 4:30 p.m. Eastern Time to discuss the results of the CRN04894 SAD cohorts. To participate, …

Category:  Health Go Health

Atumelnant (oral ACTH Antagonist) Cushing's Syndrome, CAH

WEBatumelnant* (CRN04894), Oral ACTH Antagonist. ACTH acts through the melanocortin type 2 receptor (MC2R) that is primarily expressed in the adrenal gland. This is the first reported oral, selective ACTH antagonist discovered by our team in development for the treatment of Cushing’s disease and other diseases of excess ACTH, such as congenital

Category:  Health Go Health

Acromegaly Expert Peter Trainer

WEBSAN DIEGO – November 16, 2020 – Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and …

Category:  Health Go Health

Rare Disease Day 2022 Crinetics

WEBRare Disease Day is February 28. There are 300 million people world-wide living with a rare disease. That’s why Crinetics remains committed not only to raising awareness for rare …

Category:  Health Go Health

Crinetics Pharmaceuticals Awarded Up To $3.2 Million In SBIR …

WEBCrinetics Pharmaceuticals, Inc., today announced that it has been awarded up to approximately $3.2 million in Small Business Innovation Research (SBIR) grants …

Category:  Health Go Health

Crinetics Hosting Key Opinion Leader Webinar To Discuss The …

WEBSAN DIEGO, July 10, 2023 — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that it will host a Key Opinion Leader (KOL) webinar on August 8, 2023 at …

Category:  Health Go Health

Alessandra Casagrande, M.D., Ph.D. Medical Sciences Director

WEBAlessandra Casagrande, M.D., Ph.D., Medical Sciences Director. “Neuroendocrinology has traditionally been an underserved discipline in that it doesn’t get the level of research …

Category:  Medical Go Health

Suppression of Growth Hormone and Insulin-Like Growth …

WEBTitle: Suppression of Growth Hormone and Insulin-Like Growth Factor 1 in Rats After Oral Administration of CRN00808, a Small Molecule, sst2 Selective Somatostatin Biased …

Category:  Health Go Health

Director, Health Economics And Outcomes Research (Congenital …

WEBThe Director, Health Economics and Outcomes Research (HEOR) will be responsible for developing evidence to support the Congenital Adrenal Hyperplasia (CAH) program …

Category:  Health Go Health

Crinetics Pharmaceuticals Awarded NIH Fast-Track Grant To …

WEBSAN DIEGO – April 27, 2015 – Crinetics Pharmaceuticals (“Crinetics”), an innovative therapeutics company focused on endocrine diseases and cancers, announced today …

Category:  Cancer Go Health

Crinetics Pharmaceuticals Awarded NIH Phase-II SBIR Grant To …

WEBSAN DIEGO — September 3, 2013 — San Diego-based Crinetics Pharmaceuticals announced today that it has been awarded a $2.2MM Phase II Small Business …

Category:  Health Go Health

Crinetics Pharmaceuticals Awarded NIH Phase-I SBIR Grant To …

WEBSAN DIEGO — April 28, 2014 — San Diego-based Crinetics Pharmaceuticals announced today that it has been awarded a Phase I Small Business Innovation Research (SBIR) …

Category:  Health Go Health